International drug price comparisons: Quality assessment

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 29, Issue 1, 2011, Pages 46-51

  Machado, Márcio ^a,b   O'Brodovich, Ryan ^b,c   Krahn, Murray ^a,b   Einarson, Thomas R ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Drug price; Pharmaceutical trade; Prescription drugs; Review

Indexed keywords

GENERIC DRUG;

COMPARATIVE STUDY; DATABASE; DRUGS TRADE; INCOME; PHARMACEUTICAL INDUSTRY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TRADE POLICY;

ARTICLE; BIBLIOGRAPHIC DATABASE; BIBLIOMETRICS; COMPARATIVE STUDY; COST; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG COST; ECONOMICS; HEALTH CARE QUALITY; INCOME; INTERNATIONAL COOPERATION; RESEARCH; STANDARD; STATISTICS;

BIBLIOMETRICS; COSTS AND COST ANALYSIS; DATABASES, BIBLIOGRAPHIC; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DRUG COSTS; DRUGS, GENERIC; INCOME; INTERNATIONALITY; QUALITY ASSURANCE, HEALTH CARE; RESEARCH;

SCOPUS;

EID: 79952275061     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Andersson F. Methodological aspects of international drug price comparisons. Pharmacoeconomics. 1993;4(4):247-56.
2. Tafuri G, Creese A, Reggi V. National and international differences in the pricesof branded and unbranded medicines. J Generic Med. 2004;1(2):120-7. (Pubitemid 46218653)
3. Management Sciences for Health. International Drug Price Indicator Guide; 2008.Available from: http://erc.msh.org/dmpguide/index.cfm?search-cat= yes&display=yes&module=dmp&language=english&year=2008. Accessed on 14 July 2009.
4. OECD Health. OECD Health Data 2009. Available from:http://www.ecosante. org/index2.php?base=OCDE&langs=ENG&langh=ENG&ref=YES&sessionid= 800d32b2e07d256c9d03b1c3c3eb21de. Accessed on 30 July 2009.
5. Danzon PM, Furukawa MF. International prices and availability of pharmaceuticals in 2005. Health Aff. 2008;27(1):221-33. (Pubitemid 351198606)
6. Productivity Commission. International pharmaceutical price differences. Canberra:Aus-Info; 2001. Pp. 1-91.
7. Danzon PM, Furukawa MF. Prices and availability of biopharmaceuticals: aninternational comparison. Health Aff. 2006;25(7):1353-62. (Pubitemid 44497636)
8. Wagner J, McCarthy E. International differences in drug prices. Public Health.2004;25:475-95. (Pubitemid 38543628)
9. Cohen J, Faden L, Predaris S, Yong B. Patient access to pharmaceuticals: aninternational comparison. Eur J Health Econ. 2007;8(2):253-66. (Pubitemid 47231312)
10. Ford N, Wilson D, Chaves GC, Lotrowska M, Kijtiwatchakul K. Sustaining access toantiretroviral therapy in the less-developed world: Lessons from Brazil and Thailand. AIDS. 2007; 21(suppl. 4):21S-9S.
11. Mrazek MF. Comparative approaches to pharmaceutical price regulation in theEuropean Union. Croat Med J. 2002;43(4):453-61. (Pubitemid 34976431)
12. Nobrega OT, Marques AR, de Araujo ACG, Karnikowski MG, Naves Jde O, Silver LD.Retail prices of essential drugs in Brazil: an international comparison. Rev PanamSalud Publica. 2007;22(2):118-23. (Pubitemid 350171866)
13. Roughead EE, Lopert R, Sansom LN. Prices for innovative pharmaceutical productsthat provide health gain: A comparison between Australia and the United States. ValueHealth. 2007;10(6):514-20. (Pubitemid 350013269)
14. Simoens S. International comparison of generic medicine prices. Curr Med Res Opin. 2007;23(11):2647-54. (Pubitemid 350146403)
15. Spasic S, Komrska J, Angelovska BM, Petrova GI. Drug pricing policy: Comparisonamong East European countries. Farmacia. 2004; 52(5):20-40.
16. Szuba TJ. International comparison of drug consumption: impact of prices. Soc SciMed. 1986;22(10):1019-25. (Pubitemid 16029907)
17. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability,and affordability in 36 developing and middleincome countries: a secondary analysis. Lancet. 2009;373(9659):240-9.
18. Danzon PM, Kim JD. International price comparisons for pharmaceuticals.Measurement and policy issues. Pharmacoeconomics. 1998; 14(suppl. 1):115S-28S.
19. Dickson M. The pricing of pharmaceuticals: an international comparison. Clin Ther.1992; 14(4):604-10.
20. Galanaud J, Delavennat J, Durand-Zaleski I. A break-even price calculation for theuse of sirolimus-eluting stents in angioplasty. Clin Ther. 2003;25(3):1007-16. (Pubitemid 36459705)
21. Graham JR. Explaining price differentials between Canada and the United States.Manag Care. 2004;13(suppl. 6):14S-6S.
22. Kolassa EM, Basara LR. Price comparison of an international market basket ofpharmaceuticals. Proceedings of 1994 annual meeting of the American Pharmaceutical Association. Seattle: APhA;1994.
23. Ridley DB. Price differentiation and transparency in the global pharmaceuticalmarketplace. Pharmacoeconomics. 2005;23(7):651-8. (Pubitemid 41003074)
24. Ridley DB. International price comparisons for novel and follow-on drugs. ValueHealth. 2007;10(6):510-3.
25. Simo Minana J, De Pablo Gonzalez R, Ramos Maestra MJ, Gaztambide Ganuza MS. Do we spend too much on medication? Pharmaceutical expenditure, an absolutely essential item in European countries. Aten Primaria. 2004; 33(5):244-53. (Pubitemid 38684755)
26. Smith SR. Multinational economic evaluations of pharmaceuticals. Lancet. 2002;360(9336):816. (Pubitemid 35257943)
27. Tatchell M. International drug price comparisons. Aust J Pharm. 2001;82:365.
28. Thamer M, Brennan N, Semansky R. A crossnational comparison of orphan drugpolicies: implications for the U.S. Orphan Drug Act. J Health Polit Policy Law.1998;23(2):265-90. (Pubitemid 28166785)
29. Thomas LG. Price regulation, industry structure and innovation: an internationalcomparison of pharmaceutical industries. Pharmacoeconomics. 1992;1(suppl. 1):9S-12S.
30. Van Mosseveld C. Pharmaceutical expenditure compared across countries. Can J Clin Pharmacol. 2005;12(3):e269-75.
31. Veronin MA, Nguyen NT. Comparison of simvastatin tablets from the US andinternational markets obtained via the internet. Ann Pharmacother. 2008;42(5):613-20. (Pubitemid 351619930)
32. Patented Medicine Prices Review Board. Annual report 2008: Comparison of Canadian prices to foreign prices. Available from:http://www.pmprb-cepmb.gc.ca/ english/view.asp?x=1211&mid=1015. Accessed on 11 August2009.
33. Bhat V. The impact of prices on pharmaceutical consumption-A cross-country study. Available from: http://economics.ca/2006/papers/0828.pdf. Accessed 26 July 2009.
34. Gelders S, Ewan M, Noguchi, N, Laing R. Price, availability and affordability: Aninternational comparison of chronic disease medicines. Cairo: World Health Organizationand Health Action International; 2006:1-69.
35. Nunn A, Fonseca E, Bastos FI, Gruskin S, Salomon JA. Evolution of antiretroviraldrug costs in Brazil in the context of free and universal access to AIDS treatment.PLoS Med. 2007;4(11):1804-17. (Pubitemid 350220533)
36. Palmer D'Angelo Consulting Inc. Generic drug prices: a Canada US comparison. 2002. Available from: http://www.pdci.on.ca/pdf/ Generic%20Pricing%20Study%20Final%20Report.pdf. Accessed 14 July 2009.
37. Sasich L. Report on the international comparison of prices of antidepressant and antipsychotic drugs. Public Citiz. 1997:1-12.
38. Abel A, Bernanke B, Kneebone R. Macroeconomics. 5th ed. Toronto, ON: PearsonEducation Canada; 2008.
39. World Bank. PovertyNet: Measuring inequality 2009. Available from:http://web.worldbank.org/WBSITE/EXTERNAL/TOPICS/EXTPOVERTY/EXTPA/ 0contentMDK:20238991~menuPK:492138~pagePK:148956~piPK:216618~theSitePK:43036700. html. Accessed on 6 August 2009.